Patent ID: 6939859

Claim:
A method for ameliorating cutaneous inflammation in a mammal which comprises administering thereto an effective amount of a dermatological agent for external use containing a chromanol glycoside represented by the following general formula (1) wherein R 1 , R 2 , R 3 , and R 4 , which may be the same or different, each represent a hydrogen atom or a lower alkyl group, R 5 represents a hydrogen atom, a lower alkyl group, or a lower acyl group, X represents a monosaccharic residue or an oligosaccharic residue, which may have the hydrogen atom of the hydroxyl group in the saccharic residue substituted with a lower alkyl group or a lower acyl group, n represents an integer in the range of 0-6, and m represents an integer in the range of 1-6.